636 related articles for article (PubMed ID: 32457738)
1. Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage.
Franzin R; Stasi A; Fiorentino M; Stallone G; Cantaluppi V; Gesualdo L; Castellano G
Front Immunol; 2020; 11():734. PubMed ID: 32457738
[TBL] [Abstract][Full Text] [Related]
2. Immune cells and inflammation in AKI to CKD progression.
Sato Y; Yanagita M
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1501-F1512. PubMed ID: 30156114
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial dysfunction and the AKI-to-CKD transition.
Jiang M; Bai M; Lei J; Xie Y; Xu S; Jia Z; Zhang A
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1105-F1116. PubMed ID: 33073587
[TBL] [Abstract][Full Text] [Related]
4. The Role of Mitochondria in Acute Kidney Injury and Chronic Kidney Disease and Its Therapeutic Potential.
Zhang X; Agborbesong E; Li X
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681922
[TBL] [Abstract][Full Text] [Related]
5. Acute Kidney Injury to Chronic Kidney Disease Transition.
Fiorentino M; Grandaliano G; Gesualdo L; Castellano G
Contrib Nephrol; 2018; 193():45-54. PubMed ID: 29393158
[TBL] [Abstract][Full Text] [Related]
6. A short treatment with resveratrol after a renal ischaemia-reperfusion injury prevents maladaptive repair and long-term chronic kidney disease in rats.
Martínez-Rojas MÁ; Balcázar H; Ponce-Nava MS; González-Soria I; Marquina-Castillo B; Pérez-Villalva R; Bobadilla NA
J Physiol; 2024 Apr; 602(8):1835-1852. PubMed ID: 38529522
[TBL] [Abstract][Full Text] [Related]
7. Sustained Activation of Wnt/β-Catenin Signaling Drives AKI to CKD Progression.
Xiao L; Zhou D; Tan RJ; Fu H; Zhou L; Hou FF; Liu Y
J Am Soc Nephrol; 2016 Jun; 27(6):1727-40. PubMed ID: 26453613
[TBL] [Abstract][Full Text] [Related]
8. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis.
Chen DQ; Feng YL; Chen L; Liu JR; Wang M; Vaziri ND; Zhao YY
Free Radic Biol Med; 2019 Apr; 134():484-497. PubMed ID: 30716432
[TBL] [Abstract][Full Text] [Related]
9. Cellular senescence and acute kidney injury.
Lin X; Jin H; Chai Y; Shou S
Pediatr Nephrol; 2022 Dec; 37(12):3009-3018. PubMed ID: 35338388
[TBL] [Abstract][Full Text] [Related]
10. Early elimination of uremic toxin ameliorates AKI-to-CKD transition.
Chen JH; Chao CT; Huang JW; Hung KY; Liu SH; Tarng DC; Chiang CK
Clin Sci (Lond); 2021 Dec; 135(23):2643-2658. PubMed ID: 34796904
[TBL] [Abstract][Full Text] [Related]
11. Novel insights into acute kidney injury-chronic kidney disease continuum and the role of renin-angiotensin system.
Chou YH; Huang TM; Chu TS
J Formos Med Assoc; 2017 Sep; 116(9):652-659. PubMed ID: 28615146
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D deficiency contributes to vascular damage in sustained ischemic acute kidney injury.
de Bragança AC; Volpini RA; Mehrotra P; Andrade L; Basile DP
Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27369932
[TBL] [Abstract][Full Text] [Related]
13. Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression.
Tampe B; Steinle U; Tampe D; Carstens JL; Korsten P; Zeisberg EM; Müller GA; Kalluri R; Zeisberg M
Kidney Int; 2017 Jan; 91(1):157-176. PubMed ID: 27692563
[TBL] [Abstract][Full Text] [Related]
14. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
[TBL] [Abstract][Full Text] [Related]
15. Urinary angiotensinogen predicts progressive chronic kidney disease after an episode of experimental acute kidney injury.
Cui S; Wu L; Feng X; Su H; Zhou Z; Luo W; Su C; Li Y; Shi M; Yang Z; Cao W
Clin Sci (Lond); 2018 Oct; 132(19):2121-2133. PubMed ID: 30224346
[TBL] [Abstract][Full Text] [Related]
16. Mincle receptor in macrophage and neutrophil contributes to the unresolved inflammation during the transition from acute kidney injury to chronic kidney disease.
Wang C; Zhang Y; Shen A; Tang T; Li N; Xu C; Liu B; Lv L
Front Immunol; 2024; 15():1385696. PubMed ID: 38770013
[TBL] [Abstract][Full Text] [Related]
17. AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease.
Rodríguez-Romo R; Benítez K; Barrera-Chimal J; Pérez-Villalva R; Gómez A; Aguilar-León D; Rangel-Santiago JF; Huerta S; Gamba G; Uribe N; Bobadilla NA
Kidney Int; 2016 Feb; 89(2):363-73. PubMed ID: 26509589
[TBL] [Abstract][Full Text] [Related]
18. VNN1 contributes to the acute kidney injury-chronic kidney disease transition by promoting cellular senescence via affecting RB1 expression.
Chen J; Lu H; Wang X; Yang J; Luo J; Wang L; Yi X; He Y; Chen K
FASEB J; 2022 Sep; 36(9):e22472. PubMed ID: 35959877
[TBL] [Abstract][Full Text] [Related]
19. Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis.
Menshikh A; Scarfe L; Delgado R; Finney C; Zhu Y; Yang H; de Caestecker MP
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1383-F1397. PubMed ID: 31509009
[TBL] [Abstract][Full Text] [Related]
20. Ischaemia-reperfusion injury: a major protagonist in kidney transplantation.
Ponticelli C
Nephrol Dial Transplant; 2014 Jun; 29(6):1134-40. PubMed ID: 24335382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
